$0.9600
-0.0201-2.05%
Last update: Oct 26, 12:00 PM
Werewolf Therapeutics Inc (HOWL) Stock Price, Quote, News & History
HOWLNASDAQ
Werewolf Therapeutics and Ambros Therapeutics merge in an all-stock deal with $150M in financing to advance Phase 3 CRPS-1 candidate.
You can purchase shares of Werewolf Therapeutics (NASDAQ:HOWL) through any online brokerage.
Other companies in Werewolf Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Werewolf Therapeutics has a consensus price target of $6.50.
The stock price for Werewolf Therapeutics (NASDAQ: HOWL) is $0.96 last updated October 26, 2026 at 12:00 PM EDT.
There are no upcoming dividends for Werewolf Therapeutics.
Werewolf Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Werewolf Therapeutics.
Werewolf Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary...
